Raleigh Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WAM
Raleigh Capital Management's LLY Position: Q2 2026 in Review
Raleigh Capital Management reduced its Eli Lilly (LLY) stake by 2.6% in Q2 2026, selling an estimated $46K and leaving 1,690 shares worth $2.03M. The position accounts for 0.65% of the portfolio, ranked #47.
Raleigh Capital Management first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 1,218 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Raleigh Capital Management held 1,690 shares of Eli Lilly worth $2.03M as of Q2 2026.
- Raleigh Capital Management sold 45 Eli Lilly shares in Q2 2026, an estimated $46K.
- Eli Lilly made up 0.65% of Raleigh Capital Management's portfolio in Q2 2026, its #47 holding.
- Raleigh Capital Management first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
- 1,218 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.